Literature DB >> 25520125

Time trends of nasopharyngeal carcinoma in urban Guangzhou over a 12-year period (2000-2011): declines in both incidence and mortality.

Ke Li1, Guo-Zhen Lin, Ji-Chuan Shen, Qin Zhou.   

Abstract

Nasopharyngeal carcinoma (NPC) is an uncommon disease in most countries but occurs with much greater frequency in southern China. This study aimed to examine the secular trends of NPC in urban Guangzhou over the time period of 2000-2011 using data from the Guangzhou Cancer Registry. Age-adjusted annual incidence rates of NPC were calculated by the direct method using the WHO World Standard Population (1960) as the reference. The average annual percentage change (AAPC) was used as an estimate of the trend. A total of 7,532 new cases of NPC and 3,449 related deaths were registered. In both genders, the peak incidence occurred in the 50- to 59-year age group, and this age distribution pattern remained similar throughout. The AAPC in NPC incidence rates was -3.26% (95% CI: -5.4%--1.1) for males and -5.74% (95% CI: -8.9%--2.5) for females, resulting in a total decrease of 39.3% (from 22.14 to 13.44 per 100,000 population) for males and 48.6% (from 10.1 to 5.18 per 100,000 population) for females over this 12-year period. The AAPCs in NPC mortality rates were -4.62% (95%CI: -3.5%--5.7) for males and -6.75% (95% CI: -5.2%--8.3) for females, resulting in a total decrease of -46.1% (from 12.1 to 6.54 per 100,000 population) for males and 51.7% (from 4.14 to 2.00 per 100,000 population) for females. The age-adjusted incidence and mortality rates of NPC declined during 2000-2011 in urban Guangzhou but remained high. Future efforts to improve prevention, early detection and treatment strategies are needed.

Entities:  

Mesh:

Year:  2014        PMID: 25520125     DOI: 10.7314/apjcp.2014.15.22.9899

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Active and Passive Smoking and Risk of Nasopharyngeal Carcinoma: A Population-Based Case-Control Study in Southern China.

Authors:  Ellen T Chang; Zhiwei Liu; Allan Hildesheim; Qing Liu; Yonglin Cai; Zhe Zhang; Guomin Chen; Shang-Hang Xie; Su-Mei Cao; Jian-Yong Shao; Wei-Hua Jia; Yuming Zheng; Jian Liao; Yufeng Chen; Longde Lin; Ingemar Ernberg; Thomas L Vaughan; Hans-Olov Adami; Guangwu Huang; Yi Zeng; Yi-Xin Zeng; Weimin Ye
Journal:  Am J Epidemiol       Date:  2017-06-15       Impact factor: 4.897

2.  Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma.

Authors:  A D King; J K S Woo; Q-Y Ai; F K F Mo; T Y So; W K J Lam; I O L Tse; A C Vlantis; K W N Yip; E P Hui; B B Y Ma; R W K Chiu; A T C Chan; Y M D Lo; K C A Chan
Journal:  AJNR Am J Neuroradiol       Date:  2020-03       Impact factor: 3.825

3.  Diet Quality Scores and Risk of Nasopharyngeal Carcinoma in Chinese Adults: A Case-Control Study.

Authors:  Cheng Wang; Xiao-Ling Lin; Yu-Ying Fan; Yuan-Ting Liu; Xing-Lan Zhang; Yun-Kai Lu; Chun-Hua Xu; Yu-Ming Chen
Journal:  Nutrients       Date:  2016-02-25       Impact factor: 5.717

4.  Nasopharyngeal carcinoma incidence and mortality in China, 2013.

Authors:  Kuang-Rong Wei; Rong-Shou Zheng; Si-Wei Zhang; Zhi-Heng Liang; Zhu-Ming Li; Wan-Qing Chen
Journal:  Chin J Cancer       Date:  2017-11-09

5.  Evolution of Cancer Registration Combining Online Reporting with Follow-up in the Community: Practices in Guangzhou, China

Authors:  Huazhang Liu; Guozhen Lin; Ke Li; Haiyuan Ding; Huan Xu; Yan Li; Hang Dong; Shaofang Song
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

6.  A Solo Dance or a Tango?

Authors:  Yulin Wan; Shanshan An; Yanchao Zhou; Man Tang; Qiuyun Liu
Journal:  Biochem Insights       Date:  2019-11-12

7.  Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug.

Authors:  Tatsanachat Jittreetat; Yoo Seob Shin; Hye Sook Hwang; Bok-Soon Lee; Yeon Soo Kim; Phakdee Sannikorn; Chul-Ho Kim
Journal:  Yonsei Med J       Date:  2016-05       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.